文献速递肺外科

PET在亚厘米非小细胞肺癌中的临床意义

Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2016-12-10

本研究回顾了189例术前接受PET检查的c-N0亚厘米非小细胞肺癌患者,评估SUVmax的临床意义。结果显示SUVmax是病理侵袭性的独立预测因子(p=0.0251)和总生存的预后因子(p=0.0485),预测病理侵袭性的最佳截断值为2.0。高SUVmax组(>2.0)纯实性病变和淋巴结转移比例显著更高,5年肺癌特异性生存率显著更低(92.3% vs 96.9%,p=0.0054)。

要点

  • SUVmax是亚厘米NSCLC病理侵袭性的独立预测因子(p=0.0251)。
  • SUVmax预测病理侵袭性的截断值为2.0,高SUVmax组预后更差。
  • 高SUVmax组行肺叶切除的3年无复发生存优于亚肺叶切除(88.3% vs 50.0%,p=0.0453)。

核心结论

  • PET的SUVmax反映亚厘米NSCLC的肿瘤侵袭性,对预后有重要影响,尤其在薄层CT显示纯实性病变时。

研究设计与样本

  • 回顾性研究,纳入2008至2014年间189例术前接受PET检查的c-N0亚厘米NSCLC患者,复习SUVmax。
  • 病理侵袭性定义为具备淋巴管侵犯、血管侵犯、胸膜侵犯或淋巴结转移中至少一项。
  • 生存率采用Kaplan-Meier法计算,并用log-rank检验比较。

主要发现

  • 平均SUVmax为1.7±1.8(范围0.6至13.0),中位数为1.0。
  • 28例(15%)亚厘米NSCLC患者存在病理侵袭性。
  • 多因素分析显示SUVmax是病理侵袭性的独立显著临床预测因子(p=0.0251)和总生存的预后因子(p=0.0485)。
  • ROC曲线得出预测病理侵袭性的截断值为SUVmax=2.0。
  • 高SUVmax组(>2.0,n=42)放射学纯实性病变比例显著高于低SUVmax组(≤2.0,n=147)(91% vs 14%,p<0.0001),术后淋巴结受累比例也显著更高(12% vs 0%,p<0.0001)。

关键数值与推荐

  • 预测病理侵袭性的SUVmax截断值为2.0。
  • 高SUVmax定义为SUVmax>2.0,低SUVmax定义为SUVmax≤2.0。

临床怎么用

  • 对于亚厘米NSCLC,术前PET的SUVmax可用于评估病理侵袭性和预后风险。
  • SUVmax>2.0尤其伴纯实性病变时,应警惕淋巴结转移和复发风险。
  • 高SUVmax的亚厘米NSCLC患者,肺叶切除可能较亚肺叶切除带来更好的无复发生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated the clinical significance of maximum standardized uptake value (SUVmax) on positron emission tomography (PET) in patients with subcentimeter non-small cell lung cancer (NSCLC). METHODS: Between 2008 and 2014, 189 patients were investigated preoperatively by PET for c-N0 subcentimeter NSCLC, and SUVmax was reviewed. Pathologic invasiveness (PI) was defined as having at least one of the following factors: lymphatic invasion, vascular invasion, pleural invasion, or nodal metastasis. Survival rates were calculated by Kaplan-Meier estimation methods using the log-rank test. RESULTS: Mean SUVmax was 1.7 ± 1.8 (range, 0.6 to 13.0), and the median was 1.0. PI was found in 28 (15%) patients with subcentimeter NSCLC. Multivariate analysis revealed that SUVmax was an independent significant clinical predictor of PI (p = 0.0251) and a prognostic factor of overall survival (OS) (p = 0.0485). A receiver operating characteristics curve elucidated the predictive cutoff value of PI as SUVmax = 2.0. The high-SUVmax group (SUVmax >2.0; n = 42) had significantly more radiologically pure-solid lesions (91% vs 14%; p < 0.0001) and postoperative nodal involvement (12% vs 0%; p < 0.0001) than the low-SUVmax group (SUVmax ≤2.0; n = 147). The 5-year lung cancer-specific OS (LCS-OS) elucidated significant difference between the high-SUVmax and low-SUVmax arms of the study (LCS-OS: 92.3% vs 96.9%, respectively; p = 0.0054), and cancer recurrence was found exclusively in pure-solid subcentimeter NSCLC on thin-section computed tomography. In the high-SUVmax arm of the study, lobectomy was associated with better 3-year recurrence-free survival compared with sublobar resection despite the subcentimeter disease (88.3% vs 50.0%; p = 0.0453). CONCLUSIONS: SUVmax on PET reflected tumor invasiveness and had a great impact on the prognosis of subcentimeter NSCLC, especially when a tumor showed a pure-solid appearance on a thin-section computed tomography scan.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hattori A, Matsunaga T, Takamochi K, et al. Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer. Ann Thorac Surg. 2016. PMID: 27964917. doi:10.1016/j.athoracsur.2016.09.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。